Scientists uncover new key to the puzzle of hormone therapy and breast cancer – The decreased use of postmenopausal hormone therapy has played a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer, revealed by researchers.
FDA-approved drugs fulvestrant and raloxifene eliminate, prevent cervical cancer in mice. – Researchers eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and osteoporosis. The study is published in the Proceedings of the National Academy of Sciences.
Breast density associated with increased risk of cancer recurrence — Study finds higher risk of cancer recurrence in women with dense breasts. – Women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts, revealed by researchers in a study published in the Cancer — journal of the American Cancer Society.
MRI may be unnecessary prior to treatment in most newly diagnosed breast cancer patients — New Study in Journal of the American College of Surgeons Finds Those Who Undergo MRI More Likely to Have Premature Mastectomy. – New research findings published in the August issue of the Journal of the American College of Surgeons challenge the routine use of magnetic resonance imaging (MRI) as a means to improve surgical outcomes in newly diagnosed breast cancer patients.
Women often opt to surgically remove their breasts, ovaries to reduce cancer risk – Many women at high risk for breast or ovarian cancer are choosing to undergo surgery as a precautionary measure to decrease their cancer risk, revealed by US researchers.
Stem cell ‘daughters’ lead to breast cancer — Breast cells are likely to be responsible for breast cancers. – Breast cells called luminal progenitor cells are likely to be responsible for breast cancers that develop in women carrying mutations in the gene BRCA1, revealed by researchers.
Surgery remans an option for advanced lung cancer after standard chemotherapy and radiation. – Surgery after standard chemotherapy and radiation can be an option for lung cancer patients, revealed by researchers in new study published in the Lancet.
ASTRO issues consensus statement on using APBI to treat breast cancer – A new consensus statement outlining patient selection criteria and best practices for the use of accelerated partial breast irradiation (APBI) outside the context of a clinical trial has been published in the July 15 issue of the International Journal of Radiation Oncology Biology Physics.
Study challenges routine use of MRI scans to evaluate breast cancer — Test is linked to delays in treatment, increase in mastectomy rates. – Women with newly diagnosed breast cancer who receive a breast MRI are more likely to receive a mastectomy after their diagnosis and may face delays in starting treatment, revealed by researchers.
Markers for inflammation discovered in breast cancer survivors are linked to survival – A study led by researchers at Fred Hutchinson Cancer Research Center has identified two proteins in the blood that could become important prognostic markers for long-term survival in breast cancer patients.
Low-income breast cancer patients skipping hormonal therapy, increasing their risks – Many low-income women are failing to take the hormonal therapy prescribed as part of their breast cancer treatment, possibly lowering their survival rates, according to a study led by a researcher in the Duke Comprehensive Cancer Center.
Study shows chemotherapy improves survival among older breast cancer patients – The average age of a woman diagnosed with breast cancer is 63, so it is critical to have effective proven, therapies for an older patient population.
